| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |